StemCells: Press Releases

News > Press Releases

Date	Title (click to view the full text)
8/31/2010	StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells
8/19/2010	StemCells, Inc. Reports Breakthrough Using Human Neural Stem Cells to Restore Motor Function in Chronic Spinal Cord Injury
8/10/2010	StemCells, Inc. Reports Second Quarter Financial Results and Highlights
6/30/2010	StemCells, Inc. Announces $6 Million Equity Financing
6/17/2010	StemCells, Inc. Scientists to Make Three Presentations at International Society for Stem Cell Research Annual Meeting
6/10/2010	StemCells, Inc.'s GS2-M™ Media Formulation Shown to Enhance Pluripotency of Human Stem Cells
6/8/2010	StemCells, Inc. Appoints R. Scott Greer to Board of Directors
6/3/2010	StemCells, Inc. Grants Research License to Children's Hospital of Orange County
5/27/2010	StemCells, Inc. to Present at Two Investor Conferences in June
5/6/2010	StemCells, Inc. Management to Present at World Stem Cells and Regenerative Medicine Congress
5/4/2010	StemCells, Inc. Reports First Quarter Financial Results and Highlights
5/3/2010	StemCells, Inc.'s Phase I Batten Trial Data Featured at American Association of Neurological Surgeon Annual Meeting
4/21/2010	StemCells, Inc. Plans to Advance to Second Clinical Trial in Batten Disease
3/17/2010	StemCells, Inc. Granted Broad Patent for Pluripotent Rat Stem Cells and Genetically Engineered Rats
3/11/2010	StemCells, Inc. Reports Fourth Quarter and Fiscal 2009 Financial Results
2/16/2010	StemCells, Inc. Launches Cell Culture Medium Enabling the Derivation and Maintenance of True Mouse iPS Cells
2/10/2010	StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial
2/3/2010	LifeTech Capital Initiates Research Coverage of StemCells, Inc. with Strong Speculative Buy Recommendation
1/25/2010	StemCells, Inc. Launches First Cell Culture Medium to Enable Derivation and Maintenance of True Rat Embryonic Stem Cells
12/15/2009	StemCells, Inc. Strengthens Patent Position in Embryonic and Induced Pluripotent Stem Cell Technology Platforms
12/3/2009	StemCells, Inc. Welcomes Approval of First Embryonic Stem Cell Lines Under New NIH Guidelines
11/23/2009	StemCells, Inc. CEO Martin McGlynn Featured on BioBusiness.TV's "Stem Cell Review" Series
11/23/2009	StemCells, Inc. Initiates Landmark Trial Targeting "Communication Highway" of the Brain
11/18/2009	StemCells, Inc. Provides Update on NCL Program Meeting with FDA
11/5/2009	StemCells, Inc. Reports Third Quarter Financial Results
11/3/2009	StemCells, Inc. Closes $12.5 Million Equity Financing
10/28/2009	StemCells, Inc. Announces $12.5 Million Equity Financing
10/19/2009	StemCells, Inc.'s Neural Stem Cells Show Promise for Treating Age-Related Macular Degeneration